Iomai Corp - Initial Statement of Beneficial Ownership (3)
2008年5月16日 - 6:29AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Expires:
January 31, 2008
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
INTERCELL AG
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
5/12/2008
|
3. Issuer Name
and
Ticker or Trading Symbol
IOMAI CORP [IOMI]
|
(Last)
(First)
(Middle)
CAMPUS VIENNA BIOCENTER 6
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
VIENNA, C4 1030
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
112981475
|
I
|
See footnote
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Warrant
|
3/2/2007
|
3/2/2012
|
Common Stock
|
645035
|
$5.25
|
I
|
See footnote
(1)
|
Explanation of Responses:
|
(
1)
|
Pursuant to a Voting Agreement, dated as of May 12, 2008 by and between Intercell AG and certain Iomai Corporation stockholders listed on Schedule I thereto. For a description of the terms of the Voting Agreement, please see the Form 8-K filed by Iomai Corporation with the Commission as of May 13, 2008.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
INTERCELL AG
CAMPUS VIENNA BIOCENTER 6
VIENNA, C4 1030
|
|
X
|
|
|
Signatures
|
/s/ Gerd Zettlmeissl
|
|
5/15/2008
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Iomai Corp (MM) (NASDAQ:IOMI)
過去 株価チャート
から 6 2024 まで 7 2024
Iomai Corp (MM) (NASDAQ:IOMI)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Iomai Corp (MM) (ナスダック市場): 0 recent articles
その他のIomai Corpニュース記事